Better Method for Occluding Umbilical Cord

Autor Crowley, John
Vydáno 1965

Prognostic implications of cumulative dosing in total therapy 3

Autor Barlogie, Bart, Crowley, John
Vydáno 2012

DNA cytometry testing for cervical cancer screening: approaches and reporting standards for new technologies

Autor Colditz, Graham A, Crowley, John
Vydáno 2011

Survival analysis.

Autor CROWLEY, JOHN, INSTITUTE OF MATHEMATICAL STATISTICS
Vydáno c1982

The Automatic Clinical Trial: Leveraging the Electronic Medical Record in Multi-site Cancer Clinical Trials

Autor Goodman, Keith, Krueger, Judy, Crowley, John
Vydáno 2012

Overview: Progression-Free Survival as an Endpoint in Clinical Trials with Solid Tumors

Autor Korn, Ronald L., Crowley, John J.
Vydáno 2013

Response: Top tertile SFLC reduction indeed is an independent feature of myeloma aggressiveness

Autor van Rhee, Frits, Crowley, John, Barlogie, Bart
Vydáno 2008

Seamless Phase I–II Trial Design for Assessing Toxicity and Efficacy for Targeted Agents

Autor Hoering, Antje, LeBlanc, Mike, Crowley, John
Vydáno v Clin Cancer Res (2010)

Randomized Phase III ClinicalTrial Designs forTargeted Agents

Autor Hoering, Antje, LeBlanc, Mike, Crowley, John J.
Vydáno 2008

Collapse of a hockey player: ruptured aneurysm of the renal artery

Autor Smart, Gavin W., Crowley, John S., Lavoie, Denis J.
Vydáno 2010

Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival

Autor Barlogie, Bart, Bolejack, Vanessa, Schell, Michael, Crowley, John
Vydáno 2010

Dynamics of fast and slow inhibition from cerebellar Golgi cells allow flexible control of synaptic integration

Autor Crowley, John J., Fioravante, Diasynou, Regehr, Wade G.
Vydáno 2009

End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma

Autor Hoering, Antje, Durie, Brian, Wang, Hongwei, Crowley, John
Vydáno v Future Oncol (2017)

Randomization and Statistical Power: Paramount in Trial Reproducibility (Even for Rare Cancers)

Autor Baker, Laurence H., Crowley, John J., Maki, Robert G.
Vydáno 2012

Early phase trial design for assessing several dose levels for toxicity and efficacy for targeted agents

Autor Hoering, Antje, Mitchell, Alan, LeBlanc, Michael, Crowley, John
Vydáno 2013

Fast Vesicle Replenishment and Rapid Recovery from Desensitization at a Single Synaptic Release Site

Autor Crowley, John J., Carter, Adam G., Regehr, Wade G.
Vydáno v J Neurosci (2007)

The Influence of Multivesicular Release and Postsynaptic Receptor Saturation on Transmission at Granule Cell to Purkinje Cell Synapses

Autor Foster, Kelly A., Crowley, John J., Regehr, Wade G.
Vydáno v J Neurosci (2005)

Development of optimal genetic evaluations for teat and udder structure in Canadian Angus cattle

Autor Devani, Kajal, Valente, Tiago S, Crowley, John J, Orsel, Karin
Vydáno v J Anim Sci (2019)

An Evaluation of Gene Set Analysis for Biomarker Discovery with Applications to Myeloma Research

Autor Qu, Pingping, Tian, Erming, Barlogie, Bart, Morgan, Gareth, Crowley, John
Vydáno v Frontiers of Biostatistical Methods and Applications in Clinical Oncology (2017)

Tumor Cell Gene Expression Changes Following Short-term In vivo Exposure to Single Agent Chemotherapeutics are Related to Survival in Multiple Myeloma

Autor Burington, Bart, Barlogie, Bart, Zhan, Fenghuang, Crowley, John, Shaughnessy, John D.
Vydáno 2008